JP2005517731A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517731A5
JP2005517731A5 JP2003569585A JP2003569585A JP2005517731A5 JP 2005517731 A5 JP2005517731 A5 JP 2005517731A5 JP 2003569585 A JP2003569585 A JP 2003569585A JP 2003569585 A JP2003569585 A JP 2003569585A JP 2005517731 A5 JP2005517731 A5 JP 2005517731A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
optionally
halogen
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003569585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517731A (ja
JP4647214B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/050018 external-priority patent/WO2003070675A2/en
Publication of JP2005517731A publication Critical patent/JP2005517731A/ja
Publication of JP2005517731A5 publication Critical patent/JP2005517731A5/ja
Application granted granted Critical
Publication of JP4647214B2 publication Critical patent/JP4647214B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003569585A 2002-02-22 2003-02-14 エストロゲン受容体に対して選択的に作用させるための、置換10−アリール−11H−ベンゾ[b]フルオレン及び7−アリール−5,6−ジヒドロ−ベンゾ[a]アントラセン Expired - Fee Related JP4647214B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075727 2002-02-22
EP02075729 2002-02-22
PCT/EP2003/050018 WO2003070675A2 (en) 2002-02-22 2003-02-14 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors

Publications (3)

Publication Number Publication Date
JP2005517731A JP2005517731A (ja) 2005-06-16
JP2005517731A5 true JP2005517731A5 (cg-RX-API-DMAC7.html) 2006-03-23
JP4647214B2 JP4647214B2 (ja) 2011-03-09

Family

ID=27758768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003569585A Expired - Fee Related JP4647214B2 (ja) 2002-02-22 2003-02-14 エストロゲン受容体に対して選択的に作用させるための、置換10−アリール−11H−ベンゾ[b]フルオレン及び7−アリール−5,6−ジヒドロ−ベンゾ[a]アントラセン

Country Status (11)

Country Link
US (1) US7335659B2 (cg-RX-API-DMAC7.html)
EP (1) EP1478613B1 (cg-RX-API-DMAC7.html)
JP (1) JP4647214B2 (cg-RX-API-DMAC7.html)
AR (1) AR038528A1 (cg-RX-API-DMAC7.html)
AT (1) ATE327214T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003208717A1 (cg-RX-API-DMAC7.html)
DE (2) DE60305450T8 (cg-RX-API-DMAC7.html)
ES (1) ES2265098T3 (cg-RX-API-DMAC7.html)
PE (1) PE20030981A1 (cg-RX-API-DMAC7.html)
TW (1) TW200304371A (cg-RX-API-DMAC7.html)
WO (1) WO2003070675A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016316A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE
US6849348B2 (en) * 2002-12-31 2005-02-01 Eastman Kodak Company Complex fluorene-containing compounds
US7157492B2 (en) * 2004-02-26 2007-01-02 Wyeth Dibenzo chromene derivatives and their use as ERβ selective ligands
EP1806148A4 (en) * 2004-10-22 2009-12-02 Ono Pharmaceutical Co THERAPEUTIC PREPARATION FOR INHALATION
KR20100109293A (ko) * 2009-03-31 2010-10-08 다우어드밴스드디스플레이머티리얼 유한회사 신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계발광 소자
WO2012068299A2 (en) * 2010-11-16 2012-05-24 University Of Southern California Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
CA2819299A1 (en) * 2010-12-24 2012-06-28 Merck Sharp & Dohme B.V. N-substituted azetidine derivatives
CN107188901A (zh) * 2017-05-27 2017-09-22 无锡捷化医药科技有限公司 一种(3‑(3‑(二甲氨基)丙氧基)苯基)硼酸的制备方法
CN115785148B (zh) * 2022-11-17 2024-12-10 江西科技师范大学 一种硫代膦(磷)酸酯取代苯并芴化合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5147880A (en) 1991-07-22 1992-09-15 Eli Lilly And Company Benzo[a]fluorene compounds
US5688808A (en) 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US6451817B1 (en) 1995-03-10 2002-09-17 Eli Lilly And Company Alpha-substituted-1-benzyl-napthyls
JP3141148B2 (ja) 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
CA2214935A1 (en) 1996-09-26 1998-03-26 Henry Uhlman Bryant Benzofluorene compounds, intermediates, compositions, and methods
AU7467398A (en) 1997-04-25 1998-11-24 Eli Lilly And Company Indene compounds having activity as serms
ES2293986T3 (es) * 2000-03-27 2008-04-01 N.V. Organon Compuestos no esteroides tetraciclicos para tratamientos relacionados con el estrogeno.
WO2002016316A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE

Similar Documents

Publication Publication Date Title
RU2435757C2 (ru) Производные 3-циклил-2-(4-сульфамоилфенил)-n-циклилпропионамида, применимые для лечения нарушенной переносимости глюкозы и диабета
RU2412192C2 (ru) Сульфонамидтиазолпиридиновые производные как активаторы глюкокиназы, пригодные для лечения диабета типа 2
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
EP1428822A3 (en) 1-phenylpiperazine derivative as modulators of dopamine neurotransmission
JP2018520105A5 (cg-RX-API-DMAC7.html)
RU2330019C2 (ru) Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием
JP2006521359A5 (cg-RX-API-DMAC7.html)
JP2008535803A5 (cg-RX-API-DMAC7.html)
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
CA2413086A1 (en) Benzothiazole derivatives
HUT69686A (en) Process for preparing pharmaceutical compositions having serum cholesterol lowering effect
AR047557A1 (es) Compuestos derivados de piridazina y su uso como agentes terapeuticos
JP2008536825A5 (cg-RX-API-DMAC7.html)
MY133992A (en) Muscarinic antagonists
AR031930A1 (es) Antagonistas de mch y su uso en el tratamiento de la obesidad
RU2015154955A (ru) Производные бензотиофенов в качестве ингибиторов рецептора эстрогенов
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
JP2006523234A5 (cg-RX-API-DMAC7.html)
CO5140114A1 (es) Derivados de aminoisoquinolina
RU2006112847A (ru) Производные тиазолопиридина в качестве лигандов аденозинового рецептора
RU2007102224A (ru) Производные индола в качестве антагонистов гистаминовых рецепторов
RU2011117927A (ru) Карбаматное соединение или его соль
JP2005508969A5 (cg-RX-API-DMAC7.html)
RU2000124402A (ru) Производные азетидина и пирролидина